Literature DB >> 19232234

Depressive symptoms in relation to physical functioning in pulmonary hypertension.

Karl J Looper1, Andrena Pierre, David M Dunkley, John J Sigal, David Langleben.   

Abstract

OBJECTIVE: To investigate the association between depressive symptoms and physical functioning in pulmonary hypertension (PH) patients.
METHODS: Fifty-two patients diagnosed with precapillary or postcapillary PH completed self-report questionnaires of depressive symptoms and physical functioning. Cardiac catheterization reports of patients were reviewed for hemodynamic variables.
RESULTS: Physical functioning was significantly associated with depressive symptoms on bivariate analysis. On multivariate analysis, after controlling for demographic and hemodynamic variables, depressive symptoms accounted for 9% of variance in physical functioning.
CONCLUSION: The association of depressive symptoms with decreased physical functioning in PH patients indicates the need for longitudinal research regarding the possible effect of depression on disease outcomes in this population.

Entities:  

Mesh:

Year:  2008        PMID: 19232234     DOI: 10.1016/j.jpsychores.2008.09.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  11 in total

1.  Exercise capacity affects quality of life in patients with pulmonary hypertension.

Authors:  Michael Halank; Franziska Einsle; Stephanie Lehman; Hinrich Bremer; Ralf Ewert; Heinrike Wilkens; F Joachim Meyer; Ekkehard Grünig; Hans-Jürgen Seyfarth; Martin Kolditz; Gesine Wieder; Gert Höffken; Volker Köllner
Journal:  Lung       Date:  2013-05-17       Impact factor: 2.584

2.  Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH.

Authors:  Elena Pfeuffer; Holger Krannich; Michael Halank; Heinrike Wilkens; Philipp Kolb; Berthold Jany; Matthias Held
Journal:  Lung       Date:  2017-10-09       Impact factor: 2.584

3.  Functional exercise capacity, physical activity, and respiratory and peripheral muscle strength in pulmonary hypertension according to disease severity.

Authors:  Melda Saglam; Naciye Vardar-Yagli; Ebru Calik-Kutukcu; Hulya Arikan; Sema Savci; Deniz Inal-Ince; Ali Akdogan; Lale Tokgozoglu
Journal:  J Phys Ther Sci       Date:  2015-05-26

4.  Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study.

Authors:  Janelle Yorke; Christi Deaton; Malcolm Campbell; Linda McGowen; Paul Sephton; David G Kiely; Iain Armstrong
Journal:  BMJ Open Respir Res       Date:  2018-03-01

5.  A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study.

Authors:  R M R Tulloh; V Garratt; J Tagney; J Turner-Cobb; E Marques; R Greenwood; L Howard; W Gin-Sing; A Barton; P Ewings; P Craggs; W Hollingworth
Journal:  Pilot Feasibility Stud       Date:  2018-05-21

6.  Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study.

Authors:  Laurence Halimi; Carey M Suehs; Gregory Marin; Clement Boissin; Anne-Sophie Gamez; Isabelle Vachier; Nicolas Molinari; Arnaud Bourdin
Journal:  ERJ Open Res       Date:  2021-08-23

7.  Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.

Authors:  Aaron Shengting Mai; Oliver Zi Hern Lim; Yeung Jek Ho; Gwyneth Kong; Grace En Hui Lim; Cheng Han Ng; Cyrus Ho; Roger Ho; Yinghao Lim; Ivandito Kuntjoro; Edgar Tay; James Yip; Nicholas W S Chew; Ting-Ting Low
Journal:  Front Med (Lausanne)       Date:  2022-02-17

8.  Effects of cardiopulmonary rehabilitation on pulmonary arterial hypertension: A prospective, randomized study.

Authors:  Hale Karapolat; Müyesser Ece Çınar; Göksel Tanıgör; Sanem Nalbantgil; Meral Kayıkçıoğlu; Nesrin Moğulkoç; Hakan Kültürsay
Journal:  Turk J Phys Med Rehabil       Date:  2019-05-08

Review 9.  Depression in pulmonary arterial hypertension: An undertreated comorbidity.

Authors:  Sameer Verma; Sonu Sahni; Vannan K Vijayan; Arunabh Talwar
Journal:  Lung India       Date:  2016 Jan-Feb

10.  Adaptation and validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Netherlands.

Authors:  M Wapenaar; J Twiss; M Wagenaar; P Seijkens; L van den Toorn; J Stepanous; A Heaney; A van den Bosch; K A Boomars
Journal:  Neth Heart J       Date:  2016-06       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.